RSV
Clinical trials for RSV explained in plain language.
Never miss a new study
Get alerted when new RSV trials appear
Sign up with your email to follow new studies for RSV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RSV vaccine enters human safety testing
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests the safety of a new RSV mRNA vaccine in 60 healthy adults aged 18 and older. Participants receive one of several doses or a placebo, and researchers monitor for side effects. The goal is to find a safe dose for future studies.
Matched conditions: RSV
Phase: PHASE1 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:17 UTC
-
RSV vaccine shows promise for cutting COPD attacks in High-Risk patients
Disease control Not yet recruitingThis study tests whether a respiratory syncytial virus (RSV) vaccine can reduce moderate-to-severe COPD flare-ups in people who have frequent attacks. Researchers will enroll 320 COPD patients who have had at least two flare-ups in the past year despite using standard inhalers. H…
Matched conditions: RSV
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New pill could help babies breathe easier from RSV
Disease control Not yet recruitingThis study tests a new oral drug called zelicapavir in children aged 28 days to 36 months who have RSV infection. The drug aims to stop the virus from multiplying and help symptoms clear faster. About 150 children will participate, and the study compares the drug to a placebo to …
Matched conditions: RSV
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Could a simple at-home swab replace lab tests for multiple respiratory bugs?
Diagnosis Not yet recruitingThis study checks if a new at-home nasal swab test can accurately detect COVID-19, influenza A and B, RSV, and rhinovirus. About 2000 people with cold or flu symptoms will take the test in a simulated home setting. Their results will be compared to standard lab tests to see how w…
Matched conditions: RSV
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated May 17, 2026 06:16 UTC
-
Hong kong study to track RSV's hidden toll on adults
Knowledge-focused Not yet recruitingThis study aims to find out how often RSV (a respiratory virus) causes illness in adults in Hong Kong. Researchers will collect samples from 10,000 adults with cold-like symptoms to measure infection rates and severe cases. The goal is to provide data that could guide future vacc…
Matched conditions: RSV
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated May 17, 2026 06:30 UTC